Neurovascular Interventions Market Forecast Report Available Now at Radiant Insights, Inc

Neurovascular Interventions Market Forecast Report Available Now at Radiant Insights, Inc Summary The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions market consists of four device segments including embolization, revascularization, mechanicalthrombectomy and access/support devices.

Embolization devices including bare metal and bioactive/coated coils, aneurysm remodeling devices (stents and occlusion balloons), flow diversion devices and liquid embolic agents can be used to treat intracranial aneurysms and arteriovenous malformations (AVMs) and optimize outcomes. Low-profile stent and balloon systems can be used to revascularize plaque burdened arteries in the cerebrovasculature.

Mechanical thrombectomy devices including distal and proximal devices and stent retrievers can improve recanalization rates and provide predictable outcomes in the setting of acute ischemic stroke (AIS). In addition, the next generation of access/support devices has been developed to improve navigatio n, trackability and flexibility as well as provide stable access, especially through tortuous anatomy.

Read Complete Report With TOC @ http://www.radiantinsights.com/research/medipointneurovascular-interventions-global-analysis-and-market-forecasts This report focuses on the global neurovascular interventions market in the 10 major markets (10MM) (US, France, Germany, Italy, Spain, UK, Japan, China, India, and Brazil) for treating cerebrovascular disease including intracranial aneurysms and AVMs, atherosclerotic disease, and AIS. The global neurovascular interventions market is determined for the 10 countries covered in this report and provides insight into the competitive landscape, the marketed and pipeline products, the current and emerging players and market analysis of the different device segments within the neurointerventional market. The report identifies the unmet needs in the market while providing an understanding of physicians' perceptions and decision-making processes in using neurointerventional devices; this report also evaluates the adoption of various neurointerventional devices in the future.

Highlights Key Questions Answered - The neurovascular interventions market is expected to continue its growth through the forecast period.

(Q).What are the primary patient segments, indications and different product offerings in the neurovascular interventions market?

- Endovascular therapy for cerebrovascular applications has seen rapid development in materials research and new techniques for treatment. (Q).What specific technologies/device segments will drive the market ?

(Q).What are the future trends and drivers for growth in the market?

- Innovative technologies such as flow diverters and stent retrievers have been developed to treat challenging indications. (Q).Is flow diversion a viable alternative for patients with complex aneurysms?

(Q).Will stent retrievers continue to be adopted widely in clinical practice in the future? (Q).Do we see pricing pressure in the neurointerventional devices?

- Stenting and balloon angioplasty is primarily performed in the setting of carotid artery stenosis.

(Q).What is the market potential for revascularization devices? (Q).What is the market outlook for endovascular stenting for atherosclerotic disease?

- The top players in this market have developed a broad and comprehensive portfolio of neurointerventional devices for various cerebrovascular indications. (Q).What role do smaller players have in grabbing market share in the different global regions? (Q).Who are the key players in the neurovascular interventional market?

Read Complete Report With TOC @ http://www.radiantinsights.com/research/medipointneurovascular-interventions-global-analysis-and-market-forecasts Scope - Overview of cerebrovascular disease, including epidemiology, pathophysiology, symptoms, diagnosis, and treatment guidelines and modalities.

- Annualized total neurovascular interventions market revenue by device segment, annual cost of disease and neurointerventional devices adoption pattern and procedure data from 2011-2013 and forecast for seven years to 2020.

- Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in each region covered in the report, and implications of the neurovascular interventions market.

- Pipeline analysis: Comprehensive data split across different stages of development, emerging trends and device designs in development.

- Analysis of the current and future market competition in the global neurovascular interventions market.

Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global neurovascular interventions market.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global neurovascular interventions market in the future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.

- Track device sales in the global and country-specific neurovascular interventions market from 20112020.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Read Complete Report With TOC @ http://www.radiantinsights.com/research/medipointneurovascular-interventions-global-analysis-and-market-forecasts Table of Contents 1 Table of Contents 20 1.1 List of Tables 18 1.2 List of Figures 26 2 Introduction 31 2.1 Catalyst 32

3 Clinical Outcomes 34 3.1 Disease Management 34 3.1.1 Intracranial Aneurysms 34 3.1.2 Intracranial Arteriovenous Malformations 35 3.1.3 Dural Arteriovenous Fistulas 36 3.1.4 Intracranial and Extracranial Atherosclerotic Disease 36 3.1.5 Stroke 37 3.2 Treatment Modalities 38

3.2.1 Overview 38 3.2.2 Medical/Chemical Therapy 39 3.2.3 Surgical Therapy 40 3.2.4 Endovascular Therapy 42

4 Industry Overview 53 4.1 Overview 53 4.2 Procedure Trends 53 4.2.1 Intracranial Aneurysms 53 4.2.2 Intracranial Arteriovenous Malformations 59 4.2.3 Atherosclerotic Disease 60 Read Complete Report With TOC @ http://www.radiantinsights.com/research/medipointneurovascular-interventions-global-analysis-and-market-forecasts 4.2.4 Acute Ischemic Stroke 65 4.3 Market Access 68 4.3.1 Regulatory Process 70 4.3.2 Physician Perception and Decision Making Process 76 4.3.3 Variations in Clinical Practice 82 4.3.4 Lack of Clinical Data 82 4.3.5 Regional-Level Control 83 4.3.6 Cost-Considerations 84 4.3.7 Reimbursement Trends 89 4.4 Regulatory Issues/Recalls 98 4.4.1 Regulatory Issues 98 4.4.2 Product Recalls 99 4.5 Mergers and Acquisitions/Key Partnerships 99

4.5.1 Covidien and Nfocus Neuromedical 99 4.5.2 Stryker Corporation and Surpass Medical 100 4.5.3 Covidien and MindFrame 100 4.5.4 Covidien and Reverse Medical Corporation 100 4.5.5 Stryker Corporation and Boston Scientific Neurovascular 101 4.5.6 Stryker Corporation and Concentric Medical 101 Read Complete Report With TOC @ http://www.radiantinsights.com/research/medipointneurovascular-interventions-global-analysis-and-market-forecasts 4.5.7 Covidien and ev3 102 4.5.8 Medtronic and Invatec 102 4.5.9 Johnson & Johnson and Micrus Endovascular 102 4.5.10 ev3 and Chestnut Medical Technologies 103 4.5.11 Boston Scientific Corporation and Guidant Corporation 103 4.6 Economic Impact 104 4.6.1 Economic Impact of Intracranial Aneurysms and Arteriovenous Malformations 104 4.6.2 Economic Impact of Stroke 105 4.6.3 Treatment Costs of Cerebrovascular Disease 106

5 Unmet Needs 110 5.1 Overview 110 5.2 Need for Practice, Performance, and Physician Training Guidelines 110 5.3 Lack of Clinical Data 111 5.4 Improve Management of Acute Ischemic Stroke 112 5.5 Address Complications of Surgical Therapy 114 5.6 Addressing the Challenges of Surgical Clipping 114 5.7 Lack of Optimal Treatment Strategy for Unruptured Intracranial Aneurysms 115

5.8 Need for Effective Therapies for Complex Aneurysm Morphologies and Sizes 116 5.9 Difficulty in Treating Intracranial Arteriovenous Malformations 117 5.10 Eliminating Mechanisms of Failure with Balloon Angioplasty 118 5.11 Addressing Challenges of Neurovascular Stenting 119 5.11.1 Risk of Post-Procedural Complications 119 5.11.2 In-Stent Restenosis 120 5.11.3 Stent Navigation 120 5.12 Complications of Dual Antiplatelet Therapy 120 5.13 Need to Improve Medical Therapy 121 5.14 Improve Ease of Access 122 Read Complete Report With TOC @ http://www.radiantinsights.com/research/medipointneurovascular-interventions-global-analysis-and-market-forecasts 6 Market Opportunity Analysis 123 6.1 Neurovascular Interventions Market 123 6.2 Improve Neurointerventional Device Design 123 6.3 Challenges in Treating Complex Intracranial Aneurysms and Arteriovenous Malformations 125 6.3.1 Intracranial Aneurysms 125 6.3.2 Intracranial Arteriovenous Malformations 126 6.4 Target Challenging Patient Populations 127 6.5 Optimize Care for Acute Ischemic Stroke Patients 127 6.6 Development of Drug-Eluting Devices 129 6.7 Emerging Markets 129

7 Market Drivers and Barriers 131 7.1 Market Drivers 131 7.1.1 Rising Prevalence of Disease 132

7.1.2 Improved Clinical Outcomes with Endovascular Coiling 133 7.1.3 Remodeling Techniques with Stent and Balloon-Assisted Coiling 134 7.1.4 Viable Therapeutic Option for Challenging/Complex Intracranial Aneurysms 136 7.1.5 Alternative Non-Coiling Embolization Devices for Aneurysm Treatment 137 7.1.6 Endovascular Embolization of Intracranial Arteriovenous Malformations 138 7.1.7 Imaging Assessment for Intracranial Arteriovenous Malformation Treatment 139 7.1.8 Stenting for Carotid Atherosclerotic Disease 139 7.1.9 Low-Profile Stent Systems 140 7.1.10 Improved Recanalization Rates with Mechanical Thrombectomy Devices 141 7.1.11 Cost Savings 143 Read Complete Report With TOC @ http://www.radiantinsights.com/research/medipointneurovascular-interventions-global-analysis-and-market-forecasts 7.1.12 Availability of Long-Term and Cost-Effective Data 143 7.2 Market Barriers 144 7.2.1 Complications of Neurointerventional Procedures and Devices 144 7.2.2 Lack of Clinical Data 150 7.2.3 High Cost of Treatment 150 7.2.4 Lack of Reimbursement 152 7.2.5 Lack of Superiority of Bioactive/Coated Coils 153 7.2.6 Alternative Technologies for Stroke Therapy 154 7.2.7 Regulatory Challenges: US Food and Drug Administration and European Conformity Mark 154 7.2.8 Healthcare Cost-Cutting and Reimbursement 155 7.2.9 Availability of Venture Capital 156 7.2.10 Medical Device Excise Tax 157

8 Competitive Assessment 158

8.1 Overview 158 8.2 Global Market Share 158 8.3 Marketed Products 159 8.3.1 Aachen Resonance 159 8.3.2 Abbott Vascular 161 8.3.3 Acandis 163 8.3.4 B. Braun 166 8.3.5 BALT Extrusion 167 8.3.6 Blockade Medical 172 8.3.7 Boston Scientific Corporation 173 Read Complete Report With TOC @ http://www.radiantinsights.com/research/medipointneurovascular-interventions-global-analysis-and-market-forecasts 8.3.8 Contego Medical 175 8.3.9 Cook Medical 175 8.3.10 Covidien 176 8.3.11 Gardia Medical 183 8.3.12 Gore Medical 184 8.3.13 InspireMD 186 8.3.14 ITGI Medical 187 8.3.15 Johnson & Johnson 188 8.3.16 Medikit 194 8.3.17 Medtronic 196 8.3.18 Merlin MD 199 8.3.19 MicroPort Scientific Corporation 200 8.3.20 Minvasys 202 8.3.21 Neuravi 203

8.3.22 Optimed 204 8.3.23 Penumbra 206 8.3.24 Phenox GmbH 209 8.3.25 Reverse Medical 211 8.3.26 Sequent Medical 213 8.3.27 Stryker Neurovascular Intervention 215 8.3.28 Terumo Corporation 222 8.3.29 Valor Medical 230 Read Complete Report With TOC @ http://www.radiantinsights.com/research/medipointneurovascular-interventions-global-analysis-and-market-forecasts 9 Pipeline Assessment 232 9.1 Overview 232 9.2 Pipeline by Stage of Development 232 9.3 Product Profiles 234 9.3.1 Aneurysm Occlusion Saddle 234 9.3.2 Ballstent Microcatheter 235 9.3.3 Blood Clot Removing Device 235 9.3.4 EKOS' EkoSonic Small Vessel Endovascular System 236 9.3.5 Flow-Diverting Thin-Film Nitinol Covered Stent 236 9.3.6 Ischemic Stroke System 237 9.3.7 Janjua Aneurysm Net 238 9.3.8 Multilayer Aneurysm Repair System 238 9.3.9 NAVIMAX 239 9.3.10 Palmaz Scientific Stents 240 9.3.11 Silk Road System 241 9.3.12 Transcranial Thrombectomy Catheter 242

10 Clinical Trial Analysis 243 10.1 Overview 243 10.2 Clinical Trials to Watch 244 10.2.1 Embolization 244 10.2.2 Flow Diversion 246 10.2.3 Revascularization 249 10.2.4 Mechanical Thrombectomy 250

11 Current and Future Players 253 11.1 Overview 253 11.2 Trends in Corporate Strategy 253 11.3 Company Profiles 255 Read Complete Report With TOC @ http://www.radiantinsights.com/research/medipointneurovascular-interventions-global-analysis-and-market-forecasts 11.3.1 BALT Extrusion 255 11.3.2 Covidien 258 11.3.3 Johnson & Johnson 261 11.3.4 Penumbra 266 11.3.5 Stryker Corporation 269 11.3.6 Terumo Corporation 271 11.3.7 Abbott Vascular 275 11.3.8 Boston Scientific Corporation 277 11.3.9 Cook Medical 279 11.3.10 Gore Medical 281 11.3.11 Medtronic 283 11.3.12 Aachen Resonance 285

11.3.13 Acandis 287 11.3.14 B. Braun 290 11.3.15 Blockade Medical 291 11.3.16 Contego Medical 293 11.3.17 Gardia Medical 294 11.3.18 InspireMD 296 11.3.19 ITGI Medical 298 11.3.20 Medikit 299 11.3.21 Merlin MD 300 Read Complete Report With TOC @ http://www.radiantinsights.com/research/medipointneurovascular-interventions-global-analysis-and-market-forecasts 11.3.22 MicroPort Scientific Corporation 302 11.3.23 Minvasys 303 11.3.24 Neuravi 305 11.3.25 Optimed 306 11.3.26 Phenox GmBH 308 11.3.27 Reverse Medical 309 11.3.28 Sequent Medical 311 11.3.29 Valor Medical 312 11.3.30 Other Companies 315

12 Market Outlooks 317 12.1 By Market Segment 317 12.1.1 Embolization Device Market 319 12.1.2 Revascularization Device Market 323 12.1.3 Mechanical Thrombectomy Device Market 326

12.1.4 Access/Support Device Market 329 12.2 By Geography 331 12.2.1 Global Overview 331 12.2.2 United States 332 12.2.3 The Five European Union Markets 339 12.2.4 The Asia-Pacific Region 367 12.2.5 South America 386 Read Complete Report With TOC @ http://www.radiantinsights.com/research/medipointneurovascular-interventions-global-analysis-and-market-forecasts 13 Appendix 393 13.1 Bibliography 393 13.2 Abbreviations 417 13.3 Report Methodology 423 13.3.1 Overview 423 13.3.2 Coverage 423 13.3.3 Secondary Research 423 13.4 Physicians and Specialists Included in this Study 424 13.4.1 Vivek Gupta, MD 424 13.4.2 Zsolt Kulscar, MD, PhD 424 13.4.3 Salvatore Mangiafico, MD 424 13.4.4 Thanh Nguyen, MD, FRCPc 424 13.4.5 Eduardo Wajnberg, MD 425 13.4.6 Phil White, MD 425 13.4.7 Osama O Zaidat, MD, MS, FAAN, FAHA 425 13.5 Primary Research 425 13.5.1 Primary Research - Key Opinion Leader Interviews 425

13.5.2 Expert Panel Validation 426 13.6 Forecasting Methodology 427 13.7 About the Authors 429 13.7.1 Analysts 429 13.7.2 Global Head of Healthcare 430 13.8 About MediPoint 431 13.9 About GlobalData 431 13.10 Disclaimer 431 Read Complete Report With TOC @ http://www.radiantinsights.com/research/medipointneurovascular-interventions-global-analysis-and-market-forecasts About Radiant Insights Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For More Information, Visit Radiant Insights Contact: Michelle Thoras Corporate Sales Specialist, USA Radiant Insights, Inc Phone: 1-415-349-0054 Toll Free: 1-888-202-9519 Email: sales@radiantinsights.com Blog URL: http://www.radiantinsightsinc.blogspot.com